Cilazapril monohydrate

This classification denotes an ace inhibitor with the molecular structure C22H31N3O5.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 19KW7PI29F chemically known as (1s,9s)-9-(((s)-1-carboxy-3-phenylpropyl)amino)octahydro-10-oxo-6h-pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid 9-ethyl ester monohydrate, but more commonly known as cilazapril, which bears US NIH Compound Identifier 56329. European Medicines Agency schedules Cilazapril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06265MIG. The term CILAZAPRIL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 39, no. 5, 1985, list 25. ). Most nations, for tariff and trade purposes, schedule cilazapril monohydrate under HS 29339940 and SITC 51577. As of Q4 2014, CILAZAPRIL MONOHYDRATE remains US FDA's Preferred Term for this commodity. Cilazapril monohydrate bears US NLM identifiers UMLS ID C0055723 and NCI Concept Code C76133. SMILES: CCOC(=O)[C@H](CCC1CCCCC1)N[C@H]2CCCN3CCC[C@H](N3C2=O)C(=O)O.O.